RG83 RG83 Pill - blue capsule/oblong, 18mm
Pill with imprint RG83 RG83 is Blue, Capsule/Oblong and has been identified as Diltiazem Hydrochloride Extended-Release 120 mg. It is supplied by Sun Pharmaceutical Industries Inc.
Diltiazem is used in the treatment of Atrial Fibrillation; Atrial Flutter; Heart Failure; High Blood Pressure; Angina Pectoris Prophylaxis and belongs to the drug classes calcium channel blockers, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 120 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RG83 RG83
Diltiazem Hydrochloride Extended-Release
- Imprint
- RG83 RG83
- Strength
- 120 mg
- Color
- Blue
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC)
- 63304-0718
- Inactive Ingredients
-
ammonio methacrylate copolymer type B,
sodium lauryl sulfate,
magnesium silicate,
FD&C Blue No. 1,
titanium dioxide,
ferrosoferric oxide,
propylene glycol,
potassium hydroxide,
shellac,
sucrose,
corn starch,
acetyltributyl citrate
Note: Inactive ingredients may vary.
Related images for "RG83 RG83"
More about diltiazem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (191)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blockers
- Breastfeeding
Patient resources
Other brands
Cardizem, Cartia XT, Dilt-XR, Matzim LA, ... +5 more
Professional resources
- Diltiazem Hydrochloride monograph
- Diltiazem (FDA)
- Diltiazem CD (FDA)
- Diltiazem Extended Release Tablets (FDA)
- Diltiazem Injection (FDA)
- Diltiazem Tablets (FDA)
Other brands
Cardizem, Cartia XT, Dilt-XR, Tiadylt ER, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.